First Horizon Advisors’s Novavax NVAX Stock Holding History

First Horizon Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-115	Closed	-$832	–	2428
2023 Q3	$832	Hold	115	–	–	﹤0.01%	2249
2023 Q2	$854	Hold	115	–	–	﹤0.01%	2298
2023 Q1	$796	Hold	115	–	–	﹤0.01%	2328
2022 Q4	$1.18K	Hold	115	–	–	﹤0.01%	2195
2022 Q3	$2K	Hold	115	–	–	﹤0.01%	2018
2022 Q2	$5K	Buy	115 +110	+2,200%	+$5.7K	﹤0.01%	1839
2022 Q1	$0	Sell	5 -132	-96%	-$11.8K	﹤0.01%	2107
2021 Q4	$19K	Buy	137 +21	+18%	+$3.61K	﹤0.01%	1299
2021 Q3	$23K	Buy	116 +1	+0.9%	+$220	﹤0.01%	1233
2021 Q2	$24K	Hold	115	–	–	﹤0.01%	1054
2021 Q1	$20K	Buy	+115	New	+$22.9K	﹤0.01%	1075
2014 Q1	–	Hold	0	–	–	–	1455
2013 Q4	–	Hold	0	–	–	–	1375

Other funds holding NVAX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

First Horizon Advisors's NVAX Position: Q4 2023 in Review

First Horizon Advisors sold out of Novavax (NVAX) in Q4 2023, closing a stake of 115 shares — an estimated $832 sold.

First Horizon Advisors first reported a position in NVAX in Q1 2021 and held it in 11 quarters. The position peaked at $24K in Q2 2021. 199 funds tracked by Wall St. Rank hold NVAX as of Q4 2023.

First Horizon Advisors reported no remaining Novavax position as of Q4 2023 after selling out during the quarter.
First Horizon Advisors sold 115 Novavax shares in Q4 2023, an estimated $832.
First Horizon Advisors first reported a position in Novavax in Q1 2021 and held it in 11 quarters.
First Horizon Advisors's Novavax position peaked at $24K in Q2 2021.
199 funds tracked by Wall St. Rank held Novavax as of Q4 2023.

Based on First Horizon Advisors's 13F filing for Q4 2023, filed 6 Feb 2024.